{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:25:37Z","timestamp":1774981537986,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.clindermatol.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:22:17Z","timestamp":1260940937000},"page":"17-23","source":"Crossref","is-referenced-by-count":70,"title":["Hormonal therapy for acne: why not as first line therapy? facts and controversies"],"prefix":"10.1016","volume":"28","author":[{"given":"Andreas D.","family":"Katsambas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2009.03.006_bib1","unstructured":"Gollnick H, Cunliffe W, Berson D, et al. Management of acne. J Am Acad Dermatol 2003;49:s2-s5, s20-25."},{"key":"10.1016\/j.clindermatol.2009.03.006_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1523-1747.ep12676783","article-title":"Endocrinologic control of the development and activity of the human sebaceous gland","volume":"62","author":"Pochi","year":"1974","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/1523-1747.ep12676781","article-title":"Hormonal control and methods of measuring sebaceous gland activity","volume":"62","author":"Ebling","year":"1974","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2133.1997.tb14889.x","article-title":"Activity of type 1 5 alpha reductase is greater in the follicular infrainfundibulum compared with the epidermis","volume":"136","author":"Thiboutot","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib5","series-title":"Textbook of dermatology","first-page":"1927","article-title":"Disorders of the sebaceous gland","author":"Cunliffe","year":"1998"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jcem-35-1-48","article-title":"Biologic activity of dehydroepiandrosterone sulfate in man","volume":"35","author":"Drucker","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2230.1984.tb00751.x","article-title":"Androgen status in women with late onset or persistent acne vulgaris","volume":"9","author":"Darley","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12539043","article-title":"Plasma androgens in women with acne vulgaris","volume":"81","author":"Lucky","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0015-0282(16)45254-4","article-title":"Plasma androgens and sex hormone binding globulin in the evaluation of hirsute females","volume":"35","author":"Mathur","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archderm.1983.01650340009010","article-title":"Elevated free testosterone levels in women with acne","volume":"119","author":"Schiavone","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib12","first-page":"683","article-title":"Androgen excess in women with acne","volume":"64","author":"Scholl","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/jid.1962.94","article-title":"The effects of androgens and estrogens on human sebaceous glands","volume":"39","author":"Strauss","year":"1962","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib14","first-page":"1111","article-title":"Evidence for increased androsterone metabolism in some normoandrogenic women with acne","volume":"76","author":"Carmina","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2265.1982.tb00713.x","article-title":"Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty","volume":"16","author":"Odlind","year":"1982","journal-title":"Clin Endrocrinol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1523-1747.ep12874121","article-title":"Androgen excess in women with acne alone compared with women with acne and\/or hirsutism","volume":"94","author":"Vexiau","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clindermatol.2004.03.014","article-title":"Acne: systemic treatment","volume":"22","author":"Katsambas","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/S0002-9343(99)80064-3","article-title":"Hormonal correlates of acne and hirsutism","volume":"98","author":"Lucky","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.291.6504.1231","article-title":"Treatment of acne with either tetracycline, oestrogen\/cyproterone acetate or combined therapy: a double-blind laboratory and clinical study","volume":"291","author":"Greenwood","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.1986.tb04880.x","article-title":"Anti-androgen treatment in women with acne: a controlled trial","volume":"114","author":"Miller","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: basic research and clinical perspectives","volume":"119","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","article-title":"Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)","volume":"120","author":"Thiboutot","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1529-8019.2008.00175.x","article-title":"New and emerging treatments in dermatology: acne","volume":"21","author":"Katsambas","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib24","first-page":"142","article-title":"L' acn\u00e9. Les traitements hormonaux","volume":"130","author":"Faure","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00455168","article-title":"Effect of cyproterone acetate-ethinyl estradiol treatment on the proportion of linoleic and sebaceic acids in various skin surface lipid classes","volume":"278","author":"Stewart","year":"1996","journal-title":"Arch Dermatol Res"},{"issue":"suppl 3","key":"10.1016\/j.clindermatol.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0926-9959.2001.00014.x","article-title":"Endocrinologic evaluation and hormonal therapy for women with difficult acne","volume":"15","author":"Thiboutot","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1211357","article-title":"Experience in the long-term treatment of patients with hirsutism and\/or acne with cyproterone acetate-containing preparations: efficacy, metabolic, and endocrine effects","volume":"103","author":"Van Wayjen","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib28","first-page":"157","article-title":"Efficacit\u00e9 de l'ac\u00e8tate de cyprot\u00e8rone oral associ\u00e9 \u00e0 l'ethinylestradiol dans le traitement de l'acn\u00e9 tardive de type facial","volume":"60","author":"Gollnick","year":"1999","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1365-4362.2002.01581.x","article-title":"Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia","volume":"41","author":"Mallari","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","article-title":"Acne: hormonal concepts and therapy","volume":"22","author":"Thiboutot","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","article-title":"Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro","volume":"100","author":"Akamatsu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8019.2006.00077.x","article-title":"Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing dorspirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 \u03bcg of ethinyl estradiol and 100 \u03bcg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 11","key":"10.1016\/j.clindermatol.2009.03.006_bib35","first-page":"975","article-title":"Evolution of progestins. Focus on the novel progestin drospirenone","volume":"47","author":"Thorneycroft","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1747.2004.t01-2-.x","article-title":"Regulation of human sebaceous glands","volume":"123","author":"Thiboutot","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib41","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","volume":"352","author":"James","year":"2005","journal-title":"Acne. N Engl J Med"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub2","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib43","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.det.2006.01.002","article-title":"Antiandrogen therapy for skin disease and hair disease","volume":"24","author":"Harper","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0011-8532(02)00017-4","article-title":"Antibiotics and oral contraceptives","volume":"46","author":"DeRossi","year":"2002","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(97)80322-2","article-title":"Oral contraceptive failure rates and oral antibiotics","volume":"36","author":"Helms","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archderm.1994.01690030128027","article-title":"Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives","volume":"130","author":"London","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib48","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1046\/j.1365-2133.2003.05369.x","article-title":"Congenital adrenal hyperplasia and acne in male patients","volume":"148","author":"Degitz","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000067821","article-title":"Update and future of systemic acne treatment","volume":"206","author":"Zouboulis","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000053267","article-title":"The SAHA sydnrome","volume":"54","author":"Orfanos","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1989.tb08208.x","article-title":"Most women with acne have polycystic ovaries","volume":"121","author":"Bunker","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib53","series-title":"Improving access to quality care in family planning: medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2007.12.040","article-title":"Acne and oral contraceptives: update on women's health screening guidelines","volume":"58","author":"Frangos","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib55","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/humrep\/dem259","article-title":"Misconceptions about oral contraception pills among adolescents and physicians","volume":"22","author":"Hamani","year":"2007","journal-title":"Human Reprod"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib56","first-page":"1","article-title":"Psychosocial impact of acne vulgaris: evaluating the evidence","volume":"9","author":"Tan","year":"2004","journal-title":"Skin Ther"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib57","unstructured":"Speroff L., Fritz M.A. Clinical gynecologic endocrinology and infertility, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 897, 900-2, 912, 916."},{"key":"10.1016\/j.clindermatol.2009.03.006_bib58","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib59","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicenter, case-control study","volume":"348","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib60","first-page":"9","article-title":"Cyproterone acetate (Dianette): risk of venous thromboembolism (VTE)","volume":"28","author":"CSM","year":"2002","journal-title":"Curr Prob Pharmacovigil"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib61","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"WHO","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib62","first-page":"331","article-title":"Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias","volume":"87","author":"Pini","year":"1996","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib63","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib64","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/5.6.688","article-title":"Oral contraceptives and venous thromboembolic disease. Analyses of the UK General practice research database and the UK Mediplus database","volume":"5","author":"Farmer","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humrep\/dem379","article-title":"Cyproterone acetate\/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy","volume":"23","author":"Franks","year":"2008","journal-title":"Human Reprod"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptives use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC Multicentric Case-control Study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib69","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib70","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","article-title":"Low-dose oral contraceptives: protective effect on ovarian cancer risk","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE study group. Steroid Hormones and Reproductions","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib72","series-title":"Oral contraceptives for adolescents: benefits and safety","author":"American College of Obstetricians and Gynecologists","year":"1999"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib73","series-title":"Selected practice recommendations for contraceptive use","year":"2004"},{"key":"10.1016\/j.clindermatol.2009.03.006_bib74","series-title":"Recommendations for updating selected practices in contraceptive use. Vol 1","author":"World Health Organization and US Agency for international development","year":"1994"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T09:56:21Z","timestamp":1544781381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X09000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0738081X09000522"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.03.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}